Cite
HARVARD Citation
Chemaly, R. et al. (2020). A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. Clinical infectious diseases. pp. 2777-2786. [Online].